Up a level |
Akinloye, Abdulafeez, Oyedeji, Timothy, Eniayewu, Oluwasegun, Adeagbo, Babatunde, Bolaji, Oluseye, Rannard, Steve, Owen, Andrew and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749
(2023)
Atazanavir/ritonavir increased tizoxanide exposure from oral nitazoxanide through pharmacokinetic interaction in healthy volunteers.
[Preprint]
Olagunju, Adeniyi, Bolaji, Oluseye, Amara, Alieu, Waitt, Catriona, Else, Laura, Adejuyigbe, Ebunoluwa, Siccardi, Marco, Back, David, Khoo, Saye and Owen, Andrew
(2015)
Breast milk pharmacokinetics of efavirenz and breastfed infants' exposure in genetically-defined subgroups of mother-infant pairs: an observational study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Adegbola, Adebanjo, Abutaima, Rana, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Ijarotimi, Omotade, Siccardi, Marco ORCID: 0000-0002-3539-7867, Owen, Andrew ORCID: 0000-0002-9819-7651, Soyinka, Julius and Bolaji, Oluseye
(2018)
Effect of Pregnancy on the Pharmacokinetic Interaction between Efavirenz and Lumefantrine in HIV-Malaria Coinfection.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62 (10).
e01252-e01218.
Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Schipani, Alessandro, Bolaji, Oluseye, Khoo, Saye ORCID: 0000-0002-2769-0967 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2018)
Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modelling.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73 (1).
pp. 165-172.
Eniayewu, Oluwasegun, Azuka, Uche, Ogah, Jonah, Adejuyigbe, Ebunoluwa, Bolaji, Oluseye and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749
(2023)
Pharmacogenetics of efavirenz exposure in cervicovaginal fluid during pregnancy and postpartum.
[Preprint]
Atoyebi, Shakir Adeyinka ORCID: 0000-0002-1393-3753, Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Adejuyigbe, Ebunoluwa, Owen, Andrew ORCID: 0000-0002-9819-7651, Bolaji, Oluseye, Siccardi, Marco ORCID: 0000-0002-3539-7867 and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749
(2019)
Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide <i>versus</i> efavirenz as case studies.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 140.
105068-.
Akinloye, Abdulafeez, Eniayewu, Oluwasegun, Adeagbo, Babatunde, Bolaji, Oluseye and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749
(2022)
Validation and Clinical Application of a Liquid Chromatography-Ultraviolet Detection Method to Quantify Dolutegravir in Dried Blood Spots.
THERAPEUTIC DRUG MONITORING, 44 (3).
pp. 430-437.
Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Nwogu, Jacinta, Eniayewu, Oluwasegun, Atoyebi, Shakir ORCID: 0000-0002-1393-3753, Amara, Alieu, Kpamor, John, Bolaji, Oluseye, Adejuyigbe, Ebunoluwa, Owen, Andrew ORCID: 0000-0002-9819-7651 and Khoo, Saye
(2021)
Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry.
Wellcome Open Research, 6.
p. 246.
Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Nwogu, Jacinta ORCID: 0000-0002-0640-7165, Eniayewu, Oluwasegun, Atoyebi, Shakir ORCID: 0000-0002-1393-3753, Amara, Alieu ORCID: 0000-0002-1137-2948, Kpamor, John, Bolaji, Oluseye ORCID: 0000-0002-8295-7150, Adejuyigbe, Ebunoluwa, Owen, Andrew ORCID: 0000-0002-9819-7651 and Khoo, Saye ORCID: 0000-0002-2769-0967
(2021)
Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry.
Wellcome open research, 6.
246-.